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1

Postoperative Pain Management Following Outpatient Anterior Cruciate Ligament Reconstruction – A

2

Systematic Review of Randomized Controlled Trials

3

Abstract

4

Background:

5

Effective pain management following anterior cruciate ligament reconstruction improves patient

6

satisfaction and function.

7

Purpose:

8

We collected and evaluated the available evidence from randomized controlled trials on postoperative

9

pain control following anterior cruciate ligament reconstruction.

10

Study Design:

11

Systematic review. Level 1 and 2.

12

Methods:

13

A systematic literature review was performed using PubMed, Medline, Google Scholar, UpToDate,

14

CINAHL and Scopus following PRISMA guidelines (July 2014). Only randomized control trials comparing a

15

method of postoperative pain control to another method or placebo were included.

16

Results:

17

Seventy seven randomized controlled trials met inclusion criteria, 14 on regional nerve blocks, 21 on

18

intraarticular injections, 4 on intramuscular/intravenous injections, 12 on multimodal regimens, 6 on oral

19

medications, 10 on cryotherapy/compression, 6 on mobilization and 5 on intraoperative techniques.

20

Single injection femoral nerves block provided superior analgesia to placebo for up to 24 hours

21

postoperatively, however this also resulted in a quadriceps motor deficit. Indwelling femoral catheters

22

utilized for 2 days postoperatively provided superior analgesia to a single injection femoral nerve block.

23

Local anesthetic injections at the surgical wound site or intraarticularly provided equivalent analgesia to

24

regional nerve block. Continuous infusion catheters of local anesthetic provide adequate pain relief, but

25

have been shown to cause chondrolysis.

26

Cryotherapy improved analgesia compared to no cryotherapy in 4 trials, while in 4 trials ice water and

27

room temperature water provided equivalent analgesic effects. Early weightbearing decreased pain

28

compared to delayed weightbearing.

29

Preoperative gabapentin and zolpidem for the first week postoperatively each decreased opioid

30

consumption compared to placebo. Ibuprofen reduced pain compared to acetaminophen. Oral ketorolac

31

reduced pain compared to hydrocodone-acetaminophen.

32

Conclusion:

33

Regional nerve blocks and intraarticular injections are both effective forms of analgesia. Cryotherapy-

34

compression appears beneficial provided IA temperatures are sufficiently decreased. Early mobilization

35

reduces pain symptoms. Gabapentin, zolpidem, ketorolac and ibuprofen decrease opioid consumption.

36

Despite the vast amount of high quality evidence on this topic, however, further research is needed to

37

determine the optimal multimodal approach that can maximize recovery while minimizing pain and

38

opioid consumption.

39

Clinical Relevance:

40

These results provide the best available evidence from randomized controlled trials on pain control

41

regimens for anterior cruciate ligament reconstruction.

42
43
44

45

Main Text

46

Introduction

47

The anterior cruciate ligament (ACL) is the most commonly reconstructed ligament in the knee. 73 In 2006

48

129,836 ACL reconstructions were performed in the United States, and the annual rate is increasing. 74

49

Effective postoperative pain management is a critical component to recovery, effective rehabilitation and

50

patient satisfaction. Following ACL reconstruction, psychological factors are predictive of outcomes, 36

51

and pain levels are inversely associated with function 19 and quality of life assessments. 40

52

The two main measures used to quantify patient pain symptoms are postoperative opioid medication

53

consumption and pain scales. Commonly used pain scales include the visual analog scale (VAS), verbal

54

rating scale (VRS) and the numeric rating scale (NRS). Although these methods rely on patient reporting

55

of subjective feelings, they are highly reproducible and reliable. 7, 8

56

There is an abundance of literature evaluating various postoperative pain management medications and

57

modalities following ACL reconstruction. Individual systematic reviews have analyzed the efficacy of

58

cryotherapy, 76 femoral nerve blocks (FNB), 75 continuous passive motion (CPM), 105 and postoperative

59

rehabilitation. 68 We performed a systematic review of all level I and level II randomized controlled trials

60

and present a comprehensive review of the evidence surrounding postoperative pain management for

61

outpatient arthroscopic ACL reconstruction.

62

Methods

63

A comprehensive literature review was performed to identify all randomized controlled trials (RCTs) on

64

postoperative pain management following ACL reconstruction. Searches for the terms “anterior cruciate

65

ligament” and “postoperative pain” were performed using the search engines PubMed, Medline, Google

66

Scholar, UpToDate, Cochrane Reviews, CINAHL and Scopus (from inception to July 2014). Additional

67

searches for multimodal analgesia, continuous passive motion, immobilization, early weightbearing,

68

cryotherapy, compression, intraarticular injection, nerve block, NSAIDs, hydrocodone, acetaminophen,

69

and opiates were also conducted in the same databases along with the term “anterior cruciate ligament.”

70

Reference sections of relevant articles were reviewed in an attempt to identify further relevant trials.

71

Inclusion criteria were studies that were randomized control trials, level I or II, that compared any two or

72

more pain management modalities to other modalities or placebo, utilizing objective measures to

73

quantify post-operative pain within the first postoperative month. Only modalities that can be applied to

74

postoperative pain management after ACL reconstruction in the outpatient setting were included.

75

Notation was made of the surgical methodology used in each study and this can be found in the

76

supplemental tables. All methods of arthroscopic reconstruction were included. Studies which performed

77

co-procedures such as meniscus or articular cartilage surgery alongside ACL reconstruction were

78

included. Intravenous (IV) morphine was considered valid as a pain metric but not as a treatment because

79

of our desire to evaluate “outpatient” treatment approaches. Exclusion criteria were as follows: non

80

English language or non-human articles, nonrandomized trials, studies which included patients

81

undergoing other surgical interventions alongside patients undergoing ACL reconstruction, open ACL

82

reconstruction, meta-analyses or systematic reviews of randomized controlled trials, retracted papers or

83

papers published by first authors associated with multiple cases of academic fraud, and studies which did

84

not measure pain symptoms. Data was collected including demographic information, pain outcomes and

85

complications for each included study. Wherever applicable, statistically significant results are reported.

86

PRISMA criteria were followed throughout the study. Quality appraisal was also performed for each

87

individual trial.

88

Results

89

A total of 77 RCTs met inclusion criteria for this systematic review. A PRISMA flow diagram of the

90

literature search and included studies can be found in Figure 1. Of the 77 included studies, 14 were trials

91

of regional nerve blocks, 21 were trials of intraarticular (IA) injections, 4 were trials of intramuscular (IM)

92

or intravenous (IV) injections, 12 compared differing analgesic regimens, 6 were trials on oral

93

medications, 10 were trials of cryotherapy or compression, 6 were trials of differing postoperative

94

mobilization strategies and 5 were trials of intraoperative techniques. One trial consisted of two separate

95

phases, which are presented here as individual trials. A concise summary of all interventions, which

96

resulted in a statistically significant decrease in either reported pain symptoms or opioid consumption,

97

can be found in tables 1-8. Additional information regarding each RCT including graft types, number of

98

subjects, dosages, pain metrics, rescue medications, p-values, as well as pain and medication values for

99

each comparison group can be found in tables 1-8 of the supplemental section. Complications reported in

100

association with each intervention analyzed in this systematic review are included in table 9. The costs of

101

each medication and the Medicare fee schedule for preoperative injections are included in table 10.

102

Regional Nerve Blocks (Table 2):

103

Femoral nerve block:

104

When compared to a saline injection, a single injection femoral nerve block (FNB) significantly decreased

105

VAS scores up to 60 minutes postoperatively 93 in one trial, up to the night of surgery in another, 44 and up

106

to 24 hours in a third. 48 A single injection FNB also significantly decreased postoperative morphine

107

consumption compared to saline injection. 44, 93 In a group of patients blinded to receiving a saline or

108

bupivacaine FNB injection, a supplemental bupivacaine FNB injection was offered with a reported VAS

109

score greater than 4. Significantly more patients in the saline group elected to receive the supplemental

110

FNB, with 50% of patients in the saline group doing so within 40 minutes of the completion of surgery. 87

111

Because the femoral nerve innervates the quadriceps, femoral nerve block resulted in a motor deficit in

112

all of these studies, 44, 48, 93 which persisted for the same amount of time as the analgesic effect. 87

113

Other regional nerve blocks:

114

The addition of a sciatic nerve block to a FNB yielded significantly decreased analgesic consumption and

115

NRS scores at first analgesia request compared to FNB alone. 58 As compared to a standard FNB there

116

were no significant differences in pain scores or postoperative narcotic consumption between groups

117

receiving a fascia iliaca nerve block 38 or a subsartorial saphenous nerve block. 18 The percentage of

118

patients requiring intraoperative analgesic supplementation was significantly lower when a posterior

119

psoas compartment block was used as compared to an anterior 3-in-1 FNB (femoral, obturator and lateral

120

femoral cutaneous nerves). 17

121

Patients receiving a bupivacaine bolus followed by a continuous saline infusion through a FNB catheter

122

had significantly reduced NRS pain scores and oxycodone consumption through postoperative day one as

123

compared to patients receiving placebo (saline bolus, saline infusion). Moreover, patients receiving a

124

bupivacaine bolus followed by continuous bupivacaine infusion had significantly lower NRS scores on

125

postoperative days 1, 2 and 4 and significantly lower oxycodone consumption on day 2 as compared to

126

placebo. 119 The addition of a continuous infusion of bupivacaine provided through a FNB catheter to a

127

patient controlled analgesia (PCA) device that dispensed bupivacaine boluses resulted in significantly

128

lower NRS scores compared to PCA boluses alone. 108

129

Stimulating catheters for nerve block placement:

130

FNB provided through a stimulating catheter led to significantly faster onset of anesthesia and

131

significantly lower postoperative ketorolac consumption compared to FNB performed using a

132

nonstimulating catheter. 29

133

Dosages of nerve blocks:

134

A comparison of 0.0625 % bupivacaine, 0.125% bupivacaine, and 0.25 % bupivacaine for a continuous

135

infusion FNB at 0.12 mg/kg/hour, resulted in no significant differences in VAS scores or morphine

136

consumption at any timepoint. 110 No significant differences were found in VAS scores up to 24 hours

137

when comparing a single injection FNB using 0.25 % bupivacaine, 0.20 % ropivacaine, or 0.75 %

138

ropivacaine. 121

139

Additions of other drugs to nerve blocks:

140

The addition of clonidine to a femoral-sciatic nerve block did not significantly decrease VAS scores or

141

analgesic consumption compared to femoral-sciatic nerve block alone. 23

142

Intraarticular Injections (Table 3):

143

Intraarticular bupivacaine:

144

An IA bupivacaine injection significantly decreased VAS scores compared to an IA saline injection up to 4

145

hours postoperatively 62 but not on the night of surgery. 63 A preoperative local and IA infiltration of

146

bupivacaine significantly decreased VAS scores on the night of surgery but did not significantly decrease

147

piritramid (synthetic opiod analgesic available in certain European countries) consumption as compared

148

to placebo (saline). 52 Continuous IA bupivacaine infusion significantly reduced median VAS scores 2 and

149

narcotic consumption at 48-72 hours 92 as compared to no infusion. In two of three trials continuous IA

150

bupivacaine infusion significantly reduced pain scores and rescue medication consumption compared to

151

continuous IA saline infusion. 2, 51, 92 The addition of preoperative and postoperative bupivacaine

152

infiltrations at incision sites significantly decreased analgesic consumption as compared to a single

153

postoperative IA bupivacaine injection. 16

154

Intraarticular Morphine injections:

155

IA morphine significantly decreased VAS scores and analgesic consumption compared to IA saline

156

injection 4, 12, 47, 59, 62, 106, 122 and IA methadone injection. 4, 106 A dose-dependent response was reported

157

when IA injections of 5 mg, 10 mg, and 15 mg of morphine were compared, 122 but not when 1 mg and 3

158

mg were compared. 111 A continuous 48 hour IA infusion of morphine and ropivacaine did not

159

significantly decrease VAS scores compared to IA saline infusion. 116 The addition of an IA morphine

160

injection to a 3 in 1 FNB did not significantly decrease morphine consumption or VAS scores compared to

161

the 3 in 1 FNB alone. 80

162

Combination bupivacaine-morphine intraarticular injections:

163

An IA bupivacaine-morphine injection significantly decreased VAS scores and analgesic consumption as

164

compared to IA saline, 45, 111 IA morphine alone, 111 and IA bupivacaine alone. 103, 111 One study showed no

165

significant difference in VAS scores and analgesic consumption between IA bupivacaine-morphine and IA

166

bupivacaine injections. 45 IA morphine-bupivacaine injections provided after tourniquet release

167

significantly decreased VAS scores 30 minutes after tourniquet release and analgesic consumption in the

168

first 30 minutes postoperatively compared to the same injection before tourniquet release but there

169

were no significant differences beyond these timepoints. 46

170

Other intraarticular injections

171

There were no significant differences in any measure between IA methadone and IA saline. 4, 106 IA

172

tenoxicam (a non-steroidal anti-inflammatory drug (NSAID) indicated for the short-term treatment of

173

musculoskeletal injury) significantly decreased VAS scores and supplementation of pethidine (an opioid

174

analgesic marketed under the generic name demerol which the American Pain Society does not

175

recommend for use as an analgesic 1) compared to IA saline injections. 47 IA tenoxicam resulted in

176

significantly fewer patients requiring pethidine than IA morphine. 47 The addition of IA sufentanil (a

177

fentanyl analog) to an IA ropivacaine/clonidine injection significantly decreased rescue analgesia

178

requirement during the first postoperative hour compared to IA ropivacaine/clonidine alone but did not

179

significantly decrease VAS scores at any timepoint. 3 The injection of a multidrug cocktail consisting of

180

ropivacaine, morphine, ketorolac and cefuroxime either periarticularly, or both intraarticularly and

181

periarticularly significantly decreased VAS scores in the first 24 hours compared to patients receiving no

182

injection, IA ropivacaine injection, or IA injection of the same multidrug cocktail. 63

183

Intravenous or intramuscular Injections (Table 4)

184

Rescue medication protocols:

185

There were no significant differences in VAS scores between patients receiving a standard inpatient

186

rescue medication protocol of IV morphine provided through a PCA device and patients receiving IM

187

ketorolac injection supplemented by oral (PO) oxycodone. The morphine group had a significantly higher

188

incidence of postoperative nausea and vomiting as well as urinary retention. 94

189

Various drugs injected intravenously/intramuscularly:

190

Patients receiving a postoperative 3.0 μg/kg IV fentanyl injection had significantly lower VRS scores

191

between 4 and 24 hours following surgery compared to patients receiving 1.5 μg/kg IV fentanyl both

192

preoperatively and postoperatively. 72 Intraoperative use of IV ketamine infusions significantly decreased

193

morphine consumption, but not VAS scores, as compared to an IV saline infusion. 85 IV ketorolac injection

194

significantly decreased both VAS scores and morphine consumption during the first postoperative hour

195

compared to IV saline injection. 93

196

Comparative analgesic regimens (Table 5):

197

A single-injection bupivacaine FNB did not significantly decrease VAS scores compared to a single IA

198

bupivacaine injection. 82 A single injection ropivacaine FNB significantly decreased VAS scores and total

199

morphine consumption compared to an IA ropivacaine injection. 56 A single injection preoperative FNB

200

did not significantly decrease VAS scores or analgesic consumption as compared to postoperative wound

201

site infiltration. 67 There was no significant difference in VAS scores between a preoperative IA

202

fentanyl/bupivacaine injection and a 3 in 1 FNB, however a 3 in 1 FNB significantly decreased VAS scores

203

as compared to the same IA injection administered postoperatively. 78 A femoral-sciatic nerve block

204

resulted in significantly lower VAS scores and morphine consumption as compared to an IA injection (5

205

mg morphine, clonidine and bupivacaine). 114 A continuous infusion FNB resulted in no significant

206

difference in pain scores but significantly less breakthrough pain as compared to patients receiving an IA

207

injection (10 mg morphine, ropivacaine, epinephrine). 120

208

A continuous infusion femoral-sciatic nerve block significantly decreased VAS scores and

209

morphine/ketorolac bolus administration as compared to a continuous bupivacaine IA and patellar

210

tendon wound site infusion. 28 The addition of either single-injection or continuous FNB to an IA

211

bupivacaine injection provided no significant decreases in pain scores or analgesic consumption

212

compared to IA bupivacaine injection alone. 77, 89, 102 The addition of a local bupivacaine infiltration at the

213

hamstring donor site to single injection FNB resulted in significantly decreased VAS scores up to 8 hours

214

postoperatively compared to FNB alone. 15 A combination of ketorolac IV, IA ropivacaine-morphine and

215

FNB administered prior to skin incision resulted in significantly lower VRS scores for the first 2 hours

216

postoperatively and decreased IV PCA morphine consumption as compared to the same regimen

217

administered after skin closure. 98

218

Oral Medications (Table 6)

219

The administration of 800 mg ibuprofen or a combination of 800 mg ibuprofen and 1 g acetaminophen 1

220

hour prior to surgery, and at 6 and 12 hours post-surgery resulted in significantly lower VAS scores and

221

ketobemidone (an opioid analgesic indicated for the treatment of severe pain) consumption as compared

222

to 1 g acetaminophen alone. The addition of 1 g acetaminophen to 800 mg ibuprofen was no better than

223

800 mg ibuprofen alone. 26 Patients receiving 30 mg ketorolac had significantly better total pain relief at 3

224

hours as compared to patients receiving 20 mg hydrocodone combined with 2 g acetaminophen. 5

225

Patients receiving dexamethasone and parecoxib/etoricoxib/valdecoxib (selective COX-2 inhibitor NSAIDs)

226

had significantly lower VAS scores during rest at 24 hours and consumed less morphine compared to

227

patients receiving only parecoxib/etoricoxib/valdecoxib or only dexamethasone. 25 Patients receiving

228

etoricoxib reported significantly lower VAS scores up to 8 hours postoperatively compared patients

229

receiving celecoxib or placebo. There were no significant differences in postoperative fentanyl

230

consumption. 11

231

The use of 1200 mg gabapentin preoperatively resulted in significantly lower VAS scores during the first

232

postoperative hour compared to placebo and less morphine consumption at all timepoints measured up

233

to 36 hours. No adverse events were reported. 84 The use of 10 mg zolpidem (a non-hypnotic sleep aid)

234

for the first 7 nights postoperatively resulted in significantly lower Vicodin consumption as compared to

235

placebo, however there was no difference in VAS scores. No adverse events were reported. 112 The costs

236

of these medications can be found in table 10.

237

Cryotherapy/Compression (Table 7)

238

Nine RCTs have analyzed the effects of noncompressive cryotherapy in ACL reconstruction, with 5

239

reporting decreased pain symptoms and 4 reporting no significant differences as compared to controls.

240

Postoperative cryotherapy consisting of a continuous flow cryotherapy device or a CryoCuff device

241

significantly decreased VAS scores and analgesic consumption when compared to no cryotherapy or a

242

single ice pack in the recovery room. 6, 13 In another trial a continuous flow device significantly reduced

243

analgesic consumption as compared to no cryotherapy. 22 Preoperative use of cryotherapy significantly

244

decreased percocet use on the day of surgery and VAS scores up to the morning of the first postoperative

245

day. 65 In 4 trials there were no significant differences in analgesic consumption or VAS scores between

246

cryocuff devices, ice packs, or continuous flow cooling pads with cold water or room temperature water.

247

27, 30, 35, 64

In the only study measuring IA temperatures, a cryotherapy device that maintained IA

248

temperatures 10 ° C below body temperature resulted in lower VAS scores than no cryotherapy or a 5 ° C

249

decrease. A 10 ° C decrease in IA temperatures also decreased diclofenac consumption as compared to

250

controls. No significant differences were observed between a 5 ° C decrease in IA temperatures and

251

controls. 91 No study reported any adverse events associated with the use of cryotherapy.

252

A combined cryotherapy-compression device resulted in a significantly higher percentage of patients

253

discontinuing narcotics 6 weeks postoperatively and a significantly greater decrease in VAS scores from

254

preoperative levels at 2 and 6 weeks postoperatively compared to ice packs alone. 117

255

Mobilization Strategies (Table 8)

256

Immobilization with a plaster cast for 5 weeks postoperatively did not significantly decrease the

257

proportion of patients reporting pain on the Lysholm score as compared to a hinged brace with range of

258

motion exercises beginning on postoperative day 7. 49 There were no significant differences in VAS scores

259

between an unhinged immobilizing brace for two weeks postoperatively and no immobilization.

260

Immediate postoperative weightbearing significantly decreased the proportion of patients reporting pain

261

symptoms two weeks postoperatively as compared to delaying weightbearing for two weeks

262

postoperatively, and did not lead to an increase in joint laxity. 115

263

Continuous passive motion (CPM) device usage for 16 hours per day immediately following surgery

264

significantly decreased analgesic consumption but not VAS scores compared to controls not using CPM. 79,

265

123

266

the injured leg, significantly improved proprioception but did not decrease VAS scores as compared to a

267

CPM device. 43 There were no significant differences in analgesic consumption between patients using

268

physical therapy, CPM devices or both within the first month postoperatively. 100

269

Surgical Technique (Table 8)

50

A continuous active motion (CAM) device, in which the patient used their contralateral leg to pedal

270

Patients receiving a postoperative drain reported significantly higher VAS scores in one trial, 31

271

significantly lower VAS scores in another, 61 and no significant differences in VAS scores or analgesic

272

consumption in a third 81 when compared to no drain. All 3 studies reported no complications associated

273

with the use of the drains. 31, 61, 81 Intraoperative tourniquet inflation did not significantly increase

274

morphine consumption or VRS scores as compared to no tourniquet, although it did improve

275

intraoperative visibility. 53

276

Intraoperative use of OMS103HP (an investigational drug product consisting of 13.75 mg ketoprofen, 4.52

277

mg amitriptyline, and 4.28 mg oxymetazoline added to a 3 L bag of irrigation solution which is used for

278

arthroscopic irrigation) significantly increased the percentage of patients with satisfactory pain control

279

(defined as VAS scores less than 20/100 and consuming a maximum of 2 hydrocodone/acetaminophen

280

tablets per day within the first postoperative week) as compared to standard irrigation solution. There

281

was no increase in the incidence of adverse events associated with OMS103HP use. 37

282

Quality Analysis

283

In many cases the nature of the interventions being studied limited the feasibility of blinding, however 52

284

of the trials used some form of blinding. Of these, 44 had blinded patients, 42 were double blinded, and 8

285

were triple blinded. An additional 8 trials did not have blinded patients but did have blinded assessors.

286

Graft type can influence initial post-operative pain symptoms because of harvest site pain. 42 There were

287

37 trials which used BPTB autografts exclusively and 19 which used hamstring autografts. Ten trials did

288

not list the graft type used during reconstruction, and 11 used multiple grafts within the same trial. Eight

289

of the trials which used more than one graft type included patients who received cadaveric allografts.

290

Allograft reconstructions do not involve graft harvest morbidity and pain and typically result in less initial

291

postoperative pain than autografts. 66 This represents a significant possible source of bias in these trials.

292

The pain scales used here (VAS, NRS, VRS) differed only in whether patients were asked to rate their pain

293

by marking on a continuous scale or selecting a number out of a given range. There was, however,

294

significant heterogeneity in the number of timepoints that these pain scale scores were reported. There

295

was also variability in the nature of these timepoints as some studies reported pain scores based on the

296

number of hours since the conclusion of surgery while others reported pain scores at milestones such as

297

entry into the recovery room, first analgesia request, waking the morning following surgery or discharge.

298

The time of day that surgery is conducted (morning/afternoon/evening) means that the amount of

299

elapsed time when these milestones occur will differ greatly, introducing possible bias in these studies. In

300

a RCT on cancer-related breakthrough pain a decrease of 2 points on a 0-10 VAS scale led patients to

301

forego rescue opioids. 39 This provides objective data for the use of a 2-point decrease as criteria for a

302

clinically significant result, however the definition of clinical relevance varied significantly between these

303

trials.

304

Sixty-three trials reported postoperative medication consumption using 18 different medications. In 11

305

trials it was unclear what medication was used. Morphine was the most common drug used (27 trials)

306

however this represents only 42 % of the trials measuring postoperative medication consumption. This

307

introduces variability into these results and makes comparison of rescue medication consumption

308

between studies difficult.

309

Discussion

310

ACL reconstruction is now almost solely performed on an outpatient basis. While this has been beneficial

311

in terms of patient satisfaction 69 and costs, 60 it has also complicated postoperative pain management.

312

Effective pain management in outpatient ACL reconstruction is essential because pain levels are closely

313

linked to both functional recovery 19 and quality of life assessments. 40 Currently there is no consensus

314

regarding the optimal management of pain in this setting. Therefore we undertook this study to review

315

the evidence regarding postoperative pain management following ACL reconstruction.

316

Previous systematic reviews have analyzed the efficacy of 4 of the interventions discussed here for pain

317

management following outpatient ACL reconstruction. A meta-analysis of RCTs analyzing cryotherapy use

318

found that it decreased pain (P = .02) but did not improve knee range of motion. 95 A systematic review of

319

CPM concluded that it was unclear whether or not it provided any benefit. 105 A systematic review of

320

postoperative rehabilitation methods concluded that immobilization provided no benefit and there were

321

no detrimental effects of accelerated rehabilitation. 68 A systematic review of FNB reported that single

322

injection FNB resulted in statistically significantly reduced pain in 5/13 trials, but the authors questioned

323

whether or not these decreases were clinically significant. They concluded that single injection FNB did

324

not decrease pain. 75 This systematic review, however, included studies where IA bupivacaine injections

325

were given to both the treatment group receiving FNB and the control group receiving no FNB.

326

Combining IA bupivacaine injection and FNB does not provide a synergistic analgesic effect. 77, 89, 102 FNB

327

performed in the absence of IA bupivacaine injection, however, reduces pain symptoms for up to 24

328

hours. 44, 48, 87, 93 The authors of the previous systematic review emphasized that FNB did not decrease

329

pain beyond 24 hours, but pain scores are highest immediately following surgery and decrease with time.

330

57

331

inclusion of FNB as a component of a multimodal approach to postoperative analgesia in this setting,

332

particularly if no IA injection is used.

333

Single injection nerve blocks have consistently been shown to provide superior analgesia to placebo for

334

up to 24 hours. 44, 48, 87, 93 While this is not long enough to provide effective pain management for the

335

duration of the acute recovery phase (typically 48-72 hours), pain scores are highest on the day of

336

surgery. 52 The main risk of FNB is falls, as all FNB dosages block motor output to the quadriceps. 110, 121 In

337

one study, 1.6 % of patients who received FNB suffered a fall, 104 however, subsartorial saphenous nerve

This makes the day of surgery a crucial period for effective pain relief. We believe this justifies the

338

block provided equivalent analgesia without blocking motor output. 18 This may provide a feasible

339

alternative to the traditional FNB, and we are currently investigating this. Rarer complications associated

340

with FNB include vascular puncture, 71 femoral neuritis, 104 and persistent paresthesia. 71 Stimulating

341

catheters improve the accuracy of injections at the femoral nerve 29 and reduce the risk of these

342

complications. Continuous infusion bupivacaine pumps prolong the effect of regional nerve blocks. 119

343

This prolongs the quadriceps strength deficit, necessitating effective patient education and fall prevention

344

protocols.

345

Anesthetic injections provided at either the surgical wound site or intraarticularly provide effective

346

analgesia 16, 52 which is equivalent to FNB. 82 When IA injections are utilized, we add fentanyl to the

347

injections because IA opioid injections significantly reduce postoperative pain, 4, 12, 47, 59, 62, 106, 122 are less

348

chondrotoxic than both bupivacaine and ropivacaine, 54 and are not associated with significantly

349

increased side effects as compared to placebo. 124 While much of the evidence presented here analyzed

350

the use of IA morphine, we use fentanyl because our decision to incorporate IA opioids into our practice

351

was based on an RCT analyzing IA fentanyl use in arthroscopy patients. 86

352

Continuous infusion bupivacaine pumps prolong the effect of IA injections. 2, 51, 92 However, Noyes et al.

353

reported a case series of 21 patients with disabling knee symptoms due to severe postoperative

354

chondrolysis secondary to IA bupivacaine pumps 88 and in vitro analysis revealed that 95 % of human

355

articular chondrocytes undergo apoptosis after 30 minutes of exposure to 0.5% bupivacaine. 21 We do not

356

use continuous IA bupivacaine infusions in our practice because of this risk. Only continuous infusions of

357

IA ropivicaine or bupivacaine have been shown to lead to chondrolysis in vivo, 118 however, and

358

ropivacaine is less chondrotoxic than bupivacaine in vitro. 54 This is why some physicians in our practice

359

utilize single IA ropivacaine injections.

360

In our practice we utilize either a preoperative single-injection FNB provided through a stimulating

361

catheter or an IA ropivacaine-fentanyl injection. We do not use both FNB and IA injections, because

362

combining IA bupivacaine injection and FNB does not result in a synergistic effect on pain symptoms. 77, 89,

363

102

364

exploring the use of subsartorial saphenous nerve continuous infusion blocks, because saphenous nerve

365

blocks do not block quadriceps motor output 18 and continuous infusion nerve blocks can provide longer

366

postoperative analgesia as compared with single injection regional blocks. 119

367

Cryotherapy provided effective analgesia compared to controls receiving no cryotherapy 6, 13, 22, 65 in 4

368

trials, but in 3 trials ice water provided no improvement in pain symptoms compared to room

369

temperature water. 27, 35, 64 In one study, a 10 ° C decrease below core body temperature provides an

370

analgesic effect following ACL reconstruction, while a 5 ° C decrease below core body temperature does

371

not. 91 As none of the other trials studying cryotherapy measured IA temperature, the failure to achieve

372

the required decrease in IA temperature may provide an explanation for the conflicting results regarding

373

the efficacy of cryotherapy in these studies. This makes it difficult to determine whether or not this

374

intervention is beneficial in ACL reconstruction. Combined compression-cryotherapy devices provided

375

superior analgesia 101, 117 as compared to ice packs alone. We offer cryotherapy-compression devices to

376

our patients, however insurance does not cover the cost of these devices, leading to a $150 out of pocket

377

cost to patients who choose to utilize them. This limits the wide applicability of this treatment in our

378

practice.

379

We encourage our patients to begin moving their knees early after surgery and to engage in early,

380

aggressive physical therapy because immediate weightbearing decreases pain without affecting stability.

381

115

382

recovery of function. 49, 50 CPM device usage may have some benefits, 79, 123 however early aggressive

383

physical therapy provided equivalent results 100 and it cost one group $22,200 annually to rent 10 of these

We do not commonly use continuous infusion FNB because of the associated fall risk, 104 but are

Immobilization does not decrease pain symptoms and can lead to muscular atrophy, impeding the

384

devices in 2014. 10 The combination of high costs and lack of strong evidence demonstrating decreased

385

pain symptoms with their use make it difficult to recommend CPM devices in this setting. We do not

386

utilize them in our practice for these reasons.

387

One of the main goals of pain control in the outpatient setting is to minimize the nausea, vomiting,

388

sedation, respiratory depression and pruritus associated with opioids 97 by providing safer alternatives.

389

NSAIDs provide a safer, lower risk alternative to opioids for pain medication, with oral ibuprofen providing

390

greater pain control than acetaminophen 26 and oral ketorolac providing greater pain control than a

391

combination of hydrocodone and acetaminophen. 5 There is, however, evidence from animal and in vitro

392

studies linking NSAIDs to detrimental effects on bone, ligament and tendon healing. 107 One retrospective

393

analysis linked ketorolac to an increase in anterior-posterior knee laxity following BPTB autograft ACL

394

reconstruction. 83 Although the risk of impaired healing warrants further investigation, we view NSAIDs as

395

a safe, low cost alternative to oral opioids and prescribe them to our patients for the first 5 days

396

postoperatively. Gabapentin 84 and zolpidem 112 are additional oral medications that can be beneficial in

397

reducing opioid consumption postoperatively. Gabapentin, however, can cause drowsiness and dizziness,

398

99

399

medications limit their use in our practice. The risk profiles and complications of these and other

400

interventions analyzed in this study can be found in table 9.

401

Cost analysis is extremely challenging with respect to postoperative pain management after ACL

402

reconstruction and this study was not intended to provide a true cost analysis, however we have provided

403

the costs of common medications used in table 10. The specific costs, dosages utilized and combinations

404

vary from institution to institution. It should be noted that IA injections do not incur an anesthesiologist

405

fee, while regional nerve blocks/catheters do. These non-facility fees, as determined from the 2013

406

Medicare physician fee schedule, are also listed in table 10.

and zolpidem can cause nightmares and hallucinations. 113 The associated risk profiles of these

407

This study has several strengths. It is the first comprehensive systematic review to evaluate all methods

408

of post-operative pain control following ACL reconstruction. Only Level I and Level II randomized

409

controlled trials were included, comprising the best available evidence on the topic. In addition, the

410

results have been tabulated for the reader to compare different regimens available for outpatient ACL

411

reconstruction.

412

This study is limited mainly by the quality of the studies included and heterogeneity of regimens used.

413

We restricted our study to randomized control trials to limit any effects of bias and confounding. Many of

414

the studies discussed here were based upon small patient pools, and therefore could be subject to type 2

415

errors. Additionally, wide variations in the timing of pain scale scores and postoperative rescue

416

medications made comparisons of multiple results difficult. Because of the heterogeneity in

417

measurement techniques and the wide breadth of interventions studied, a combination of data in the

418

form of a meta-analysis was not attempted.

419

In accordance with this evidence reviewed in this systematic review, our current multimodal approach to

420

pain control involves a preoperative single injection femoral nerve block or intraarticular

421

ropivacaine/fentanyl injection, intraoperative tourniquet use, NSAIDs for the first 5 days postoperatively,

422

cryotherapy/compression (optional due to associated cost), early weightbearing, early aggressive physical

423

therapy, and oral percocet as needed. However, there is little evidence regarding the optimal utilization

424

of evidence-supported modalities in this setting and additional research is needed to compare differing

425

multimodal regimens.

426

Conclusions

427

This study presents and evaluates the currently available randomized, controlled studies on postoperative

428

pain management after ACL surgery. Nerve blocks and intraarticular injections are both effective forms of

429

analgesia. Cryotherapy appears to be beneficial provided IA temperatures are sufficiently decreased, and

430

is most effective when employed in conjunction with compression. Early mobilization reduces pain

431

symptoms. Several oral medications, namely gabapentin, zolpidem, ketorolac and ibuprofen, provide

432

effective, reliable alternatives to opioids. Despite the vast amount of high quality evidence on this topic,

433

however, no consensus exists on the ideal regimen. Further research is needed to determine the optimal

434

multimodal approach that can maximize recovery while minimizing pain and opioid consumption.

435
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771
772

Table 1: Significant results of RCTs analyzing pain outcomes following regional nerve block in ACL
reconstruction
Mulroy et al., Harris et al.,
Femoral nerve block superior to saline injection or no injection
Frost et al., Peng et al. 44, 48, 87,
93

Jansen et al. 58
Cappelleri et al. 17
Williams et al. 119
Svediene et al. 108
Dauri et al. 29

Femoral-sciatic nerve block superior to femoral nerve block
Posterior psoas approach to 3-in-1 femoral nerve block superior to
anterior approach to 3-in-1 femoral nerve block
Continuous infusion femoral nerve block superior to single injection
femoral nerve block
Basal FNB bupivacaine infusion with on-demand boluses superior to
on-demand boluses alone
Femoral nerve block from stimulating catheter superior to femoral
nerve block from nonstimulating catheter

773
774
775
776

Any intervention resulting in a statistically significant decrease in subjective pain scores or pain
medication consumption is included in this table. Additional information regarding these trials can be
found in table 1 of the supplemental section.

777
778

Table 2 – Significant results of RCTs analyzing pain outcomes for intraarticular injections in ACL
reconstruction
Karlsson et al. 62
Intraarticular bupivacaine injection superior to intraarticular saline
injection
Guler et al., Arti et al., Stewart Intraarticular morphine injection superior to intraarticular saline
et al., Brandsson et al., Joshi et injection
al., Yari et al., Karlsson et al. 4,
12, 47, 59, 62, 106, 122

Tetzlaff et al., Yari et al. 111, 122
Arti et al., Stewart et al. 4, 106
Yari et al. 122
Vintar et al. 116

Butterfield et al. 16

Parker et al., Alford et al. 2, 92
Parker et al., Hoenecke et al.,
Alford et al.2, 51, 92
Guler et al. 47
Armellin et al. 3
Koh et al. 63

Intraarticular injection of morphine and bupivacaine superior to
intraarticular bupivacaine injection
Intraarticular morphine injection superior to intraarticular
methadone injection
Intraarticular injection of bupivacaine and 15 mg morphine superior
to intraarticular injection of bupivacaine and 5 mg morphine
Patient controlled analgesia device dispensing intraarticular
ropivacaine-morphine-ketorolac infusion superior to patient
controlled analgesia device dispensing intraarticular saline infusion
Preoperative and postoperative bupivacaine infiltrations and
intraarticular bupivacaine injection superior to intraarticular
bupivacaine injection
Continuous intraarticular bupivacaine infusion superior to no infusion
in 1 of 2 trials
Continuous intraarticular bupivacaine infusion superior to continuous
intraarticular saline infusion in 2 of 3 trials
Intraarticular tenoxicam injection superior to intraarticular morphine
injection
Intraarticular injection of ropivacaine, clonidine and sufentanil
superior to intraarticular injection of ropivacaine and clonidine
Periarticular or periarticular/intraarticular injection of ropivacaine,
morphine, ketorolac and cerufoxime superior to intraarticular
injection of ropivacaine, morphine, ketorolac and cerufoxime

779
780
781
782

Any intervention resulting in a statistically significant decrease in subjective pain scores or pain
medication consumption is included in this table. Additional information regarding these trials can be
found in table 2 of the supplemental section.

783
784

Table 3 – Significant results of RCTs analyzing pain outcomes following intramuscular/Intravenous
injections in ACL reconstruction
Menigaux et al. 85
Intravenous ketamine superior to intravenous saline
Peng et al. 93
Intravenous ketorolac superior to intravenous saline
72
Lenz et al.
Postoperative 3.0 μg/kg intravenous fentanyl injection superior to 1.5
μg/kg intravenous fentanyl injection both preoperatively and
postoperatively

785
786
787
788

Any intervention resulting in a statistically significant decrease in subjective pain scores or pain
medication consumption is included in this table. Additional information regarding these trials can be
found in table 3 of the supplemental section.

789
790

Table 4 – Significant results of RCTs analyzing pain outcomes of differing analgesia regimens in ACL
reconstruction
Mehdi et al., Iskandar et al. 56,
Single injection femoral nerve block superior to single intraarticular
82
bupivacaine injection in 1 of 2 trials
28
Dauri et al.
Continuous infusion femoral nerve block superior to continuous
intraarticular and wound site bupivacaine infiltration
114
Tran et al.
Femoral-sciatic nerve block superior to intraarticular injection of
bupivacaine + 5 mg morphine
Mayr et al. 78
3-in-1 femoral nerve block superior to postoperative intraarticular
fentanyl-bupivacaine injection
Woods et al. 120
Continuous infusion FNB superior to intraarticular injection of
bupivacaine and 10 mg morphine with available oxycodone tablets
Bushnell et al. 15
Femoral nerve block with hamstring autograft donor site bupivacaine
infiltration superior to femoral nerve block alone
98
Rosaeg et al.
Preoperative intravenous ketorolac, intraarticular ropivacainemorphine injection and femoral nerve block superior to the same
multimodal regimen employed postoperatively

791
792
793
794

Any intervention resulting in a statistically significant decrease in subjective pain scores or pain
medication consumption is included in this table. Additional information regarding these trials can be
found in table 4 of the supplemental section.

795
796

Table 5 – Significant results of RCTs analyzing pain outcomes following oral medications for ACL
reconstruction
Dahl et al. 26
Oral ibuprofen superior to oral acetaminophen
Barber et al. 5
Oral ketorolac superior to oral hydrocodone and acetaminophen
25
Dahl et al.
Oral dexamethasone and parecoxib/etoricoxib/valdecoxib superior to
oral dexamethasone/parecoxib/etoricoxib/valdecoxib
11
Boonriong et al.
Oral eteroicoxib superior to oral celecoxib or placebo
Menigaux et al. 84
Oral gabapentin superior to oral placebo
112
Tompkins et al.
Oral zolpidem superior to oral placebo

797
798
799
800

Any intervention resulting in a statistically significant decrease in subjective pain scores or pain
medication consumption is included in this table. Additional information regarding these trials can be
found in table 5 of the supplemental section.

801
802

Table 6 – Significant results of RCTs analyzing pain outcomes for cryotherapy and compression in ACL
reconstruction
Barber et al., Brandsson et al., Cryotherapy superior to no cryotherapy or room temperature water
Cohn et al., Daniel et al.,
in 4 of 8 trials
Dervin et al., Edwards et al.,
Konrath et al., Koyonos et al. 6,
13, 22, 27, 30, 35, 64, 65

Waterman et al. 117
Ohkoshi et al. 91

Cryotherapy and compression superior to cryotherapy alone
10 ° C intraarticular decrease below body temperature superior to 5 °
C intraarticular decrease below body temperature or no cryotherapy

803
804
805
806

Any intervention resulting in a statistically significant decrease in subjective pain scores or pain
medication consumption is included in this table. Additional information regarding these trials can be
found in table 6 of the supplemental section.

807
808

Table 7 – Significant results of RCTs analyzing pain outcomes with differing mobilization strategies for ACL
reconstruction
Tyler et al. 115
Immediate postoperative weightbearing superior to delayed
postoperative weightbearing
79,
Mccarthy et al., Yates et al.
Continuous passive motion device use superior to no continuous
123
passive motion

809
810
811
812

Any intervention resulting in a statistically significant decrease in subjective pain scores or pain
medication consumption is included in this table. Additional information regarding these trials can be
found in table 7 of the supplemental section.

813
814

Table 8 – Significant results of RCTs analyzing pain outcomes following differing intraoperative techniques
for ACL reconstruction
Dhawan et al., Karahan et al.,
Postoperative drain insertion superior to no drain in 1 of 3 trials
Mccormack et al. 31, 61, 81
Fanton et al. 37

Arthroscopic irrigation solution containing experimental drug
OMS103HP superior to standard irrigation solution

815
816
817
818
819

Any intervention resulting in a statistically significant decrease in subjective pain scores or pain
medication consumption is included in this table. Additional information regarding these trials can be
found in table 8 of the supplemental section.

820
821

Table 9 – Possible complications associated with interventions used for pain control following ACL
reconstruction
Intervention
Single injection femoral nerve
block
Continuous infusion femoral nerve
block
Continuous intraarticular
bupivacaine infusion
Bupivacaine/Ropivacaine
Ketamine
Opioids
NSAIDs
COX-2 Inhibitors
Acetaminophen
Gabapentin
Zolpidem
Cryotherapy
CPM device
Intraarticular drain
Tourniquet

Complications
Decreased quadriceps motor function and fall risk, 97 vascular
puncture, 71 persistent paresthesia 71
Bacterial catheter colonization, 24 permanent nerve injury 55
Chondrolysis leading to articular cartilage degeneration 88
Cardiac arrest, 32 seizure, 41
Sedation, sleep pattern change, dizziness, depersonalization,
hallucinations 20
Dependency, nausea, vomiting, sedation, respiratory
depression, pruritus 97
Gastrointestinal bleeding, 70 decreased bone, ligament and
tendon healing 107
Thrombosis 9
Hepatotoxicity 14
Drowsiness, dizziness, ataxia and confusion 99
Nightmares, hallucinations 113
Nerve palsy 33
Increased wound drainage and wound complications 90
Increased need for transfusion, 96 bacterial colonization 34
Venous thromboembolic events 109

822
823
824
825

Complications for each intervention are based on a literature review and do not reflect the results of the
individual randomized controlled trials presented in this systematic review.

826

Table 10 – Costs associated with medications used for pain control following ACL reconstruction
Medication*
Injectable
Bupivacaine pf 0.5%
Bupivacine pf 0.5%
Ropivacaine pf 0.5%
Morphine 2 mg
ketorolac 30 mg
Epinephrine 1/100000
Fentanyl 50 mcg/ml
Ketamine 50 mg/ml
Dexamethasone 4mg
PCA
Fentanyl 10 mcg/ml
Hydromorphone 0.2 mg/ml
Oral
Hydrocodone
Ibuprofen
Acetaminophen
Celecoxib
Zolpidem
Injections 
Single sciatic nerve injection
Continuous sciatic nerve
infusion
Single femoral nerve
injection
Continuous femoral nerve
infusion

Unit Dose

Cost/Fee

10 ml vial
30 ml vial
30 ml vial
1 ml carpuject
1 ml vial
1 ml ampule
2 ml vial
10 ml vial
1 ml vial

$
$
$
$
$
$
$
$
$

55 ml syringe
50 ml syringe

$ 12.20
$ 11.90

2 mg tablet
200 mg tablet
325 mg tablet
200 mg tablet
5 mg tablet

$
$
$
$
$

1.21
1.30
6.35
1.77
1.79
1.27
1.00
2.70
0.68

0.16
0.30
0.02
1.95
0.04

$139.15
$78.59
$121.46
$70.43

827
828

*Medication costs acquired from large tertiary care hospital pharmacy.

829

 Non-facility fees acquired from 2013 Medicare physician fee schedule – national average.
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831
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833
834

Figure 1 – Literature review results according to PRISMA criteria

